Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chart: FDA Semi-Annual Regulatory Agenda Targets

This article was originally published in The Tan Sheet

FDA Semi-Annual Regulatory Agenda Targets



List of OTC drug and dietary supplement priorities from HHS semi-annual regulatory agenda in the April 26 Federal Register.

Category

Status

Date

Antacid products

Final actions; sodium bicarbonate labeling / overindulgence labeling

TBD

Antidiarrheal drugs

NPRM; new labeling

TBD

Category II active ingredients

Final action; certain OTC drug ingredients not GRASE or misbranded

TBD

Cough/cold (antihistamine)

NPRM; claims

3/11

Cough/cold (allergy/ bronchodilators/antiasthmatics)

NPRM; pediatric dosing

12/10

Cough/cold (bronchodilators)

Final action; single-ingredient labeling

9/10

Cough/cold (combinations)

Final action; monograph amendment

3/11

Cough/cold (nasal decongestants)

Final action; phenylpropanolamine

TBD

Dietary supplement GMPS

Final action; IFR on identity testing waivers

TBD

Internal analgesics (acetaminophen)

NPRM; safety

3/11

NPRMs; pediatric dosing / sodium bicarbonate monograph amendment

TBD

External analgesics

Final action; GRASE for patches, plasters and poultices

12/10

Infant formula

Final action; quality control procedures, notification requirements, records and reports, and quality factors

10/10

Labeling requirements

End review of current regulation

5/10

Final action; convenience-size packages

TBD

Laxatives

NPRM; professional labeling for sodium phosphate products

10/10

NPRM; professional labeling for other laxative products

TBD

Final action; monograph amendment

TBD

Modernization of food GMPs

NPRM

3/11

Ophthalmic products

Final action; monograph for emergency first-aid eyewash products

TBD

Oral health care

NPRM; monograph amendment for products indicated to reduce or prevent dental plaque and gingivitis

TBD

Overindulgence in food/drink products

Final action; products containing bismuth subsalicylate

TBD

Skin protectant products

Final actions; ingredients for diaper rash / fever blisters and cold sores

3/11

Sunscreen

NPRM; time and extent applications

7/10

NPRM; effectiveness

10/10

Final action; UVA/UVB formulation

10/10

NPRM; sunscreen and insect repellent products

TBD

Skin bleaching products

Final action; hydroquinone

TBD

Stimulant drug products

NPRM; hangover amendment

TBD

Topical antimicrobials

NPRMs; food handler products / testing requirements for health care professional products / consumer products

TBD

Urinary analgesics

NRPM; pain relief

TBD

Vaginal contraceptive products

NPRM; monograph

TBD

Weight-control products

NRPM; use of benzocaine

TBD

Final action; phenylpropanolamine

TBD

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104106

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel